Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]

View source ↗

Summary

Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally advanced or metastatic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Urothelial Carcinoma

Drugs mentioned

• RO7496353

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-small Cell Lung Cancer, Gastric Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING